| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Address reprint requests to: Address correspondence to: Karen H. Lu, MD, The Department of Gynecological Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd. Box 440, Houston, TX; e-mail: khlu{at}mdanderson.org.
OBJECTIVE: Endometrial cancer is the most common gynecologic malignancy in the United States. The mean age at diagnosis is 61 years; however, 5–30% of women are aged younger than 50 years at the time of diagnosis. The objective of this study was to conduct a clinical and pathologic review of endometrial cancers diagnosed in premenopausal women aged younger than 50 years, to better identify the risk factors for this subgroup of women.
METHODS: We conducted a retrospective cohort study of patients with histologically confirmed endometrial cancer treated at the University of Texas, M. D. Anderson Cancer Center from 1989 to 2003. Clinical characteristics including age, body mass index (BMI), parity, diabetes, and personal or family history of cancer were obtained from the medical record. Pathologic information was obtained from pathology reports.
RESULTS: Twelve percent (188/1531) of all patients with endometrial adenocarcinoma were aged younger than 50 years. The mean age at diagnosis was 41 years (range 21–49 years). Mean BMI was 34 kg/m2 (range 18–68); 58% of patients had a BMI of 30 or greater. Fifty-five percent were nulliparous and 39% reported irregular menstrual cycles. The incidence of both diabetes and hypertension was 23%. Thirty-six patients (19%) had synchronous ovarian cancers.
CONCLUSION: We found that the majority of patients diagnosed with endometrial cancer at a young age were obese and nulliparous. In addition, we found a high incidence of synchronous primary ovarian cancers in this cohort of young, premenopausal women.
LEVEL OF EVIDENCE: III
This article has been cited by other articles:
|
|
 |
|
  A. Parthasarathy, D. S. Kapp, M. K. Cheung, J. Y. Shin, K. Osann, and J. K. Chan Adjuvant Radiotherapy in Incompletely Staged IC and II Endometrioid Uterine Cancer Obstet. Gynecol., December 1, 2007; 110(6): 1237 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Lu, J. O. Schorge, K. J. Rodabaugh, M. S. Daniels, C. C. Sun, P. T. Soliman, K. G. White, R. Luthra, D. M. Gershenson, and R. R. Broaddus Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer J. Clin. Oncol., November 20, 2007; 25(33): 5158 - 5164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Lee, M. K. Cheung, J. Y. Shin, A. Husain, N. N. Teng, J. S. Berek, D. S. Kapp, K. Osann, and J. K. Chan Prognostic Factors for Uterine Cancer in Reproductive-Aged Women Obstet. Gynecol., March 1, 2007; 109(3): 655 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Onega, J. Baron, and T. MacKenzie Cancer after Total Joint Arthroplasty: A Meta-analysis. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1532 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Taylor, M. A. Powell, R. K. Gibb, J. S. Rader, P. C. Huettner, S. N. Thibodeau, D. G. Mutch, and P. J. Goodfellow MLH3 Mutation in Endometrial Cancer. Cancer Res., August 1, 2006; 66(15): 7502 - 7508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gerber, A. Krause, T. Reimer, I. Mylonas, J. Makovitzky, G. Kundt, and W. Janni Anastrozole versus Tamoxifen Treatment in Postmenopausal Women with Endocrine-Responsive Breast Cancer and Tamoxifen-Induced Endometrial Pathology Clin. Cancer Res., February 15, 2006; 12(4): 1245 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. McGrath, D. S. Michaud, and I. De Vivo Hormonal and Reproductive Factors and the Risk of Bladder Cancer in Women Am. J. Epidemiol., February 1, 2006; 163(3): 236 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Soliman, R. R. Broaddus, K. M. Schmeler, M. S. Daniels, D. Gonzalez, B. M. Slomovitz, D. M. Gershenson, and K. H. Lu Women With Synchronous Primary Cancers of the Endometrium and Ovary: Do They Have Lynch Syndrome? J. Clin. Oncol., December 20, 2005; 23(36): 9344 - 9350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Minerva BMJ, April 30, 2005; 330(7498): 1034 - 1034. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
